Outlook Therapeutics Inc (OTLK)

8.71 -0.21 (-2.35%) USD  |  NASDAQ  |  May 01, 11:27
More

Outlook Therapeutics Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2016. Upgrade now.
Date Value
June 29, 2023 39.89
June 28, 2023 40.75
June 27, 2023 40.38
June 26, 2023 38.67
June 23, 2023 42.83
June 22, 2023 42.34
June 21, 2023 42.83
June 20, 2023 43.32
June 16, 2023 44.30
June 15, 2023 43.56
June 14, 2023 41.11
June 13, 2023 40.14
June 12, 2023 40.38
June 09, 2023 42.34
June 08, 2023 42.58
June 07, 2023 46.25
June 06, 2023 43.81
June 05, 2023 42.83
June 02, 2023 39.28
June 01, 2023 39.89
May 31, 2023 36.71
May 30, 2023 36.71
May 26, 2023 36.10
May 25, 2023 33.04
May 24, 2023 36.46
Date Value
May 23, 2023 37.20
May 22, 2023 39.89
May 19, 2023 32.79
May 18, 2023 29.86
May 17, 2023 29.37
May 16, 2023 29.12
May 15, 2023 29.37
May 12, 2023 28.14
May 11, 2023 27.65
May 10, 2023 28.88
May 09, 2023 28.63
May 08, 2023 27.90
May 05, 2023 28.14
May 04, 2023 27.16
May 03, 2023 27.41
May 02, 2023 27.16
May 01, 2023 28.63
April 28, 2023 25.70
April 27, 2023 25.94
April 26, 2023 26.43
April 25, 2023 26.68
April 24, 2023 26.68
April 21, 2023 28.63
April 20, 2023 29.12
April 19, 2023 28.14

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

5.604
Minimum
Jan 11 2022
85.41
Maximum
Oct 07 2021
26.99
Average
20.35
Median

Price to Book Value Benchmarks

Cutera Inc --
Actinium Pharmaceuticals Inc 6.254
GT Biopharma Inc 0.5855
Karyopharm Therapeutics Inc --
Marinus Pharmaceuticals Inc 4.718

Price to Book Value Related Metrics

PS Ratio 13.82
Price 8.71
Earnings Yield -45.92%
Market Cap 188.00M